Michelle Morrow, Ph.D

Michelle Morrow, Ph.D

Head of invoX Therapeutic Innovation (iTI)
15+ years’ R&D experience in immuno-oncology and antibody research in biotech and large pharma. Formerly at Cambridge Antibody Technology, Medimmune/AstraZeneca and F-star Therapeutics.